ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

FAB Fusion Antibodies Plc

3.75
-0.05 (-1.32%)
31 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Fusion Antibodies Plc LSE:FAB London Ordinary Share GB00BDQZGK16 ORD 4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.05 -1.32% 3.75 3.70 3.80 3.80 3.75 3.80 474,407 11:29:57
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 2.9M -2.6M -0.0272 -1.38 3.58M
Fusion Antibodies Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker FAB. The last closing price for Fusion Antibodies was 3.80p. Over the last year, Fusion Antibodies shares have traded in a share price range of 3.10p to 9.875p.

Fusion Antibodies currently has 95,365,564 shares in issue. The market capitalisation of Fusion Antibodies is £3.58 million. Fusion Antibodies has a price to earnings ratio (PE ratio) of -1.38.

Fusion Antibodies Share Discussion Threads

Showing 201 to 223 of 4100 messages
Chat Pages: Latest  20  19  18  17  16  15  14  13  12  11  10  9  Older
DateSubjectAuthorDiscuss
21/7/2020
15:09
no stock at all at 93p.
tomboyb
21/7/2020
12:37
fab rise today
also heads up ,webinar tomorrow ncyt ,is rns going to be released there today / tomorrow

bunz3
21/7/2020
12:32
My broker online has 15 shares available at 90p -
tomboyb
21/7/2020
12:14
Can anyone buy? -
tomboyb
15/7/2020
20:57
AstraZeneca jumps 7% ahead of COVID-19 vaccine update https://seekingalpha.com/news/3591485-astrazeneca-jumps-7-ahead-of-covidminus-19-vaccine-update
fhasson
06/7/2020
21:38
Trying to discern what’s so negative about this update to justify today’s share price fall
cbeadle
16/6/2020
10:35
As fears over the pandemic have lifted to an extent, certain companies' share prices have fallen back somewhat.With many experts predicting a second wave, these companies' could quickly come back into fashion...#ODX #FAB #SNG #NCYT #ORPH #AVCT #WSGhttps://total-market-solutions.com/2020/06/16/covid-19-updated/
burtond1
14/6/2020
13:04
FAB Research Note Part 2
maverick247
06/6/2020
18:19
Long article in Daily Mail on Antibodies.
vivgav
21/5/2020
21:09
https://docs.google.com/document/d/1IvYHzLa_pdLNGQzRdhVIas6XtCpW5ATEEudQt9Je3fk/mobilebasic
maverick247
20/5/2020
14:09
If Doc likes it expect funding to come your way. Dr Bucket shop.
tidy 2
20/5/2020
08:36
Here, @DDS_DocHoliday caught up with @FsnAntibodies CFO James Fair to learn more about the business and who they are.#FAB offers a complete range of antibody-related services in Discovery, Engineering, and Supply...https://twitter.com/tmsreach/status/1263009722334097408?s=21
burtond1
18/5/2020
11:08
Held back by the recent fundraising but hopefully now they will start going forward
cbeadle
12/5/2020
16:01
That was a lot of info packed into 13 minutes. Let’s hope the confidence translates into a working therapeutic antibody to help fight Covid-19.
gwr7
12/5/2020
13:21
Proactive Investor 12/5/20

Fusion Antibodies PLCFusion Antibodies CEO sees 'enormous value' in discovery platform as it expands to include COVID-19

Fusion Antibodies PLC (LON:FAB) CEO Paul Kerr speaks to Proactive London's Andrew Scott following their oversubscribed £3mln fundraise.

He says they now have the resources to carry out additional proof-of-concept work on their Mammalian Antibody Library Discovery Platform, which has been expanded to include COVID-19, as well as for their existing oncology targets.

moneymunch
12/5/2020
13:17
This should start moving big time with the first tranche of placing shares admitted tomorrow followed by the AGM on Friday for shareholder approval for the next batch for the following week, and of course news/update could drop at anytime thereafter....only 26m shares is issue following the placing, and so could be highly sort after on good news, especially Covid-19 related. Gla :-)
moneymunch
08/5/2020
07:04
6/5/20


Paul Kerr, CEO of Fusion Antibodies, talks about the company's recent placing to raise £3m along with an update around Covid-19 and plans for the rest of the year.

moneymunch
04/5/2020
18:58
thank you tim for putting the complete chart up .
haroldthegreat
04/5/2020
18:16
Impressive shareholder list

Crescent Capital II LP 2,652,325 12.01%
Viridian Growth Fund LP 1,831,500 8.29%
Hargreave Hale Limited 1,402,439 6.35%
Amati Global Investors Limited 1,341,463 6.07%
Jim Johnston 1,317,325 5.96%
Livingbridge VC LLP 1,219,512 5.52%
Octopus Investments Limited 1,219,512 5.52%
Unicorn AIM VCT plc 1,219,512 5.52%
Invest Northern Ireland 974,450 4.41%
Crescent Capital III LP 731,707 3.31%
QUBIS Limited 709,375 3.21%

Director share holdings
Dr Paul Gerard Kerr 1 540,710 2.41%
Dr Richard John Buick 495,125 2.24%
Dr Simon Gordon Douglas 255,800 1.16%
Dr Alan Mawson 2 128,988 0.58%
Sonya Maria Ferguson 60,900 0.14%
Timothy William Watts 27,575 0.12%

ianb5004
04/5/2020
10:41
Looks like FAB could be primed for takeoff
cbeadle
04/5/2020
10:16
Great article for anyone who wants to get up to speed quickly on FAB and what they are doing on COVID19 amongst other things
justsomeguy
04/5/2020
09:27
Starting to get funky see 250p here pretty quick 3-400p on real momentum GLA
maverick247
03/5/2020
10:31
Covid 19 review by @tmsreachhttps://total-market-solutions.com/2020/05/01/covid-19-company-review/
burtond1
Chat Pages: Latest  20  19  18  17  16  15  14  13  12  11  10  9  Older

Your Recent History

Delayed Upgrade Clock